cyclophosphamide/fluorouracil/methotrexate/prednisone/tamoxifen protocol

Known as: CTX/5-FU/MTX/PRED/TMX, CMFPT, CMFPT protocol 
 

Topic mentions per year

Topic mentions per year

1980-2006
01219802006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Ovarian and adrenal function were studied in premenopausal breast cancer patients before and at intervals during adjuvant therapy… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1993
1993
Neoadjuvant therapy for locally advanced breast cancer improves disease control, but the complications of treatment are not well… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1990
1990
The current trial was designed to assess whether the addition of prednisone or prednisone + tamoxifen would enhance the… (More)
Is this relevant?
1990
1990
A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate… (More)
Is this relevant?
1989
1989
The Eastern Cooperative Oncology Group (ECOG) trial of adjuvant cyclophosphamide, methotrexate, fluorouracil, and prednisone… (More)
Is this relevant?
Review
1988
Review
1988
Risk factors for isolated local-regional (LR) recurrence following mastectomy for breast cancer were analyzed in a review of 627… (More)
Is this relevant?
1986
1986
Separate trials for premenopausal and postmenopausal (less than or equal to 65 yr of age) patients with node-positive breast… (More)
Is this relevant?
1985
1985
After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal… (More)
Is this relevant?
1980
1980
Ovarian and adrenal function were studied in premenopausal breast cancer patients before and at intervals during adjuvant therapy… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?